|
Re: Technical Difficulties
|
2
|
Resverlogix Corp.
|
Oct 11, 2017 01:12PM
|
|
Re: Targeting Epigenetics as a New Therapy in Vascular Disease and Dementia
|
6
|
Resverlogix Corp.
|
Aug 29, 2019 02:44PM
|
|
Re: Targeting Epigenetics as a New Therapy in Vascular Disease and Dementia
|
4
|
Resverlogix Corp.
|
Aug 29, 2019 08:12PM
|
|
Re: Talking about an SSRA like its a slam dunk????
|
4
|
Resverlogix Corp.
|
Jun 25, 2018 02:38PM
|
|
Re: Take Home Points: not ready for use in patients
|
7
|
Resverlogix Corp.
|
Nov 16, 2019 04:29PM
|
|
Re: Tailwinds Research biOasis video
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 09, 2017 10:48AM
|
|
Re: system wide...
|
2
|
Resverlogix Corp.
|
Oct 29, 2017 02:55PM
|
|
Re: Symposium at ESC in Barcelona
|
1
|
Resverlogix Corp.
|
Aug 26, 2017 10:11AM
|
|
Re: Symposium at ESC in Barcelona
|
1
|
Resverlogix Corp.
|
Aug 26, 2017 11:44AM
|
|
Re: Surprising.....
|
5
|
Resverlogix Corp.
|
Oct 01, 2019 10:52AM
|
|
Re: Surprising.....
|
5
|
Resverlogix Corp.
|
Oct 01, 2019 04:07PM
|
|
Re: Summary of Proposed BETonMACE2 design and timelines
|
3
|
Resverlogix Corp.
|
Feb 05, 2021 08:01AM
|
|
Re: Summary of Proposed BETonMACE2 design and timelines
|
3
|
Resverlogix Corp.
|
Feb 06, 2021 03:53PM
|
|
Re: Summary of Proposed BETonMACE2 design and timelines
|
4
|
Resverlogix Corp.
|
Feb 12, 2021 09:45AM
|
|
Re: Success or Failure?
|
4
|
Resverlogix Corp.
|
Oct 05, 2019 11:43PM
|
|
Re: Success or Failure?
|
6
|
Resverlogix Corp.
|
Oct 06, 2019 09:03AM
|
|
Re: Sub-study Forest Plot
|
8
|
Resverlogix Corp.
|
Nov 16, 2019 03:02PM
|
|
Re: Sub-study Forest Plot
|
2
|
Resverlogix Corp.
|
Nov 16, 2019 03:11PM
|
|
Re: Study Demonstrates Resverlogix’s Apabetalone Significantly Improves Cognition & Reduces Cognitive Decline Among Patients with Both CVD & Diabetes
|
7
|
Resverlogix Corp.
|
Sep 13, 2021 10:00AM
|
|
Re: Strong Movement Today
|
5
|
Resverlogix Corp.
|
Sep 01, 2015 04:43PM
|
